Chun H - Search Results

1

Homoharringtonine is safe and effective for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Among authors: chun h. Leukemia. 1992 Nov;6(11):1185-8. Leukemia. 1992. PMID: 1434802 Clinical Trial.

2

Higher cure rates in acute leukemia: now more probable with increasingly effective induction therapy.

Arlin ZA, Ahmed T, Mittelman A, Cook P, Puccio CA, Helson L, Chun HG. Arlin ZA, et al. Among authors: chun hg. Int J Clin Lab Res. 1992;21(4):273-7. doi: 10.1007/BF02591660. Int J Clin Lab Res. 1992. PMID: 1591379 Review.

3

"Quality" remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatment.

Arlin ZA, Feldman EJ, Finger L, Ahmed T, Mittelman A, Puccio C, Cook P, Chun HG. Arlin ZA, et al. Among authors: chun hg. Semin Hematol. 1991 Jul;28(3 Suppl 4):44-7. Semin Hematol. 1991. PMID: 1780752 Review. No abstract available.

4

Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia.

Arlin ZA, Feldman EJ, Mittelman A, Ahmed T, Puccio C, Chun HG, Cook P, Baskind P, Marboe C, Mehta R. Arlin ZA, et al. Among authors: chun hg. Cancer. 1991 Sep 15;68(6):1198-200. doi: 10.1002/1097-0142(19910915)68:6<1198::aid-cncr2820680603>3.0.co;2-e. Cancer. 1991. PMID: 1873770

5

Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.

Razis E, Arlin ZA, Ahmed T, Feldman EJ, Puccio C, Cook P, Chun HG, Helson L, Mittelman A. Razis E, et al. Among authors: chun hg. Acta Haematol. 1994;91(4):171-4. doi: 10.1159/000204328. Acta Haematol. 1994. PMID: 7976113

6

Phase II Trial of Fludarabine Phosphate in Multiple Myeloma Using a Loading Dose and Continuous Infusion Schedule.

Lichtman SM, Mittelman A, Budman DR, Puccio CA, Chun HG, Allen SL, Ahmed T, Arlin ZA. Lichtman SM, et al. Among authors: chun hg. Leuk Lymphoma. 1991;6(1):61-3. doi: 10.3109/10428199109064880. Leuk Lymphoma. 1991. PMID: 27457577

7

Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia.

Feldman E, Arlin Z, Ahmed T, Mittelman A, Puccio C, Chun H, Cook P, Baskind P. Feldman E, et al. Among authors: chun h. Leukemia. 1992 Nov;6(11):1189-91. Leukemia. 1992. PMID: 1434803 Clinical Trial.

8

Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas.

Ahmed T, Cook P, Feldman E, Coombe N, Puccio C, Mittelman A, Chun H, Coleman M, Helson L. Ahmed T, et al. Among authors: chun h. Leukemia. 1994 Apr;8(4):531-4. Leukemia. 1994. PMID: 8152247 Clinical Trial.

9

Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319).

Mittelman A, Chun HG, Puccio C, Coombe N, Lansen T, Ahmed T. Mittelman A, et al. Among authors: chun hg. Invest New Drugs. 1999;17(2):179-82. doi: 10.1023/a:1006379402114. Invest New Drugs. 1999. PMID: 10638489 Clinical Trial.

10

Improving the "quality of remission induction" therapy: a necessary step for increasing the cure rate in acute myelogenous leukemia.

Arlin ZA, Feldman E, Finger L, Decter J, Cook P, Ahmed T, Puccio C, Chun H, Mittelman A. Arlin ZA, et al. Among authors: chun h. Cancer Invest. 1992;10(2):183-4. doi: 10.3109/07357909209032779. Cancer Invest. 1992. PMID: 1551027 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,008 results

Search Page

Filters